Faculty Profile
Dr. Bazhenova Lyudmila Bazhenova, M.D.
Assistant Clinical Professor of Medicine
Division of Hematology-Oncology
Medical Director, Moores UCSD Cancer
Center Infusion Center
Office Address:
Division of Hematology-Oncology
University of California, San Diego
Moores UCSD Cancer Center
3855 Health Sciences Drive, MC-0987
La Jolla, CA 92093
Office: (858) 822-6189
FAX: (858) 822-6190
| Education/Training | Research Interests | Publications | Laboratory |
Education and Training
| MD | Nizhny Novgorod State Medical Academy, Nizhny Novgorod, Russia | 1988-1994 |
| Resident, Chief Resident and Research Fellowship | Clinical Hospital #38,Nizhny Novgorod State Medical Academy Nizhny Novgorod, Russia |
1994-1995 |
Intern/Resident |
UCLA VA Medical Center | 1999-2002 |
| Fellowship | Hematology-Oncology, Scripps-Green Hospital, La Jolla, CA |
2002-2005 |
Research Interests
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators. She believes in a multidisciplinary approach to lung cancer when radiation and surgery plays an important role in patient management. She leads a weekly lung tumor board, so patients can benefit from input of different sub-specialists.
Publications
Mena-Duran A, Togo S, Bazhenova L, et al. SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factor. Br J Hematol, June 2005, Vol. 129 Issue 6, 791-794.
Bazhenova L, Du E, Bhoyrul S, McCallum J, Saven A. Reactive thrombocytosis associated with a pheochromocytoma. Thrombosis and Hemostasis, 2005, Aug; 94(2):460-2.
Bazhenova L, Higginbottom P, Mason J. Intravascular lymphoma: a role for single agent Rituximab. Leukemia/Lymphoma, 2006, Feb; 47(2) 337-341.
Peterson M, Piao Z, Bazhenova L, Yi J. Terminal respiratory unit type lung adenocarcinoma is associated with distinctive EGFT immunoreactivity and EGFR mutations. Applied Immunohistochemistry and Molecular Morphology, 2007, Sept; 15(3):242-7.
Bazhenova L, Hampshire A, Saven A. Indications for the treatment and treatment of hairy cell leukemia. In: Clinical Malignant Hematology, MA Sekeres, ed., McGraw-Hill, 2007, pgs 285-294.
Bazhenova L. Thymoma and thymic carcinoma. Invited entry for Encyclopedia of Cancer and Society. Edited by G. Golditz, SAGE publications, 2007.
